help button home button Endocrine Society JCEM JCEM Call for Nominations for EIC
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

Journal of Clinical Endocrinology & Metabolism, doi:10.1210/jc.2006-0216
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
91/8/2967    most recent
Author Manuscript (PDF)
Right arrow Submit a related Letter to the Editor
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Orio, F.
Right arrow Articles by Vigorito, C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Orio, F., Jr.
Right arrow Articles by Vigorito, C.
Related Collections
Right arrow Cardiovascular Endocrinology
Right arrow Female Endocrinology
The Journal of Clinical Endocrinology & Metabolism Vol. 91, No. 8 2967-2971
Copyright © 2006 by The Endocrine Society

Cardiopulmonary Impairment in Young Women with Polycystic Ovary Syndrome

Francesco Orio, Jr., Francesco Giallauria, Stefano Palomba, Teresa Cascella, Francesco Manguso, Laura Vuolo, Tiziana Russo, Achille Tolino, Gaetano Lombardi, Annamaria Colao and Carlo Vigorito

Departments of Molecular and Clinical Endocrinology and Oncology (F.O., T.C., L.V., G.L., A.C.), Obstetrics and Gynecology (A.T.), and Clinical Medicine (F.G., C.V.), Cardiovascular and Immunological Sciences, Cardiac Rehabilitation Unit, University "Federico II" Naples, 80131 Naples, Italy; Department of Obstetrics and Gynecology (S.P., T.R.), University "Magna Graecia" of Catanzaro, 88100 Catanzaro, Italy; and Gastroenterology Unit (F.M.), "Cardarelli" Hospital, 80131 Naples, Italy

Address all correspondence and requests for reprints to: Francesco Orio, M.D., Ph.D., Department of Molecular, Clinical Endocrinology, and Oncology, University "Federico II" of Naples, Via S. Pansini 5, 80131 Naples, Italy. E-mail: francescoorio{at}virgilio.it.

Context: Insulin resistance is a feature of polycystic ovary syndrome (PCOS), and it is related to mitochondrial function, particularly with maximal oxygen consumption (VO2max). At the moment, no evaluation of cardiopulmonary functional capacity in young patients with PCOS has been performed.

Objective: Our objective was to assess cardiopulmonary functional capacity in young PCOS overweight patients.

Design and Setting: We conducted a prospective baseline-controlled clinical study at University "Federico II" of Naples, School of Medicine (Naples, Italy).

Patients: Forty-five PCOS patients were matched with 45 healthy women for age (mean ± SD, 21.3 ± 2.0 vs. 21.6 ± 1.9 yr, respectively) and body mass index (29.4 ± 3.6 vs. 29.0 ± 3.4 kg/m2, respectively).

Mean Outcome Measures: We assessed hormonal and metabolic pattern and functional capacity by cardiopulmonary exercise testing to evaluate maximal oxygen consumption (VO2max), oxygen consumption at anaerobic threshold (VO2AT), and the maximal workload at peak exercise.

Results: VO2max (17.0 ± 3.7 vs. 26.8 ± 3.5 ml/kg·min), oxygen consumption at anaerobic threshold (13.9 ± 3.0 vs. 21.2 ± 3.8 ml/kg·min), and maximal workload at peak exercise (101.3 ± 25.2 vs. 135 ± 22.6 W) were significantly (P < 0.001) reduced in PCOS subjects compared with healthy women. The multiple linear regression analysis showed that only homeostasis model assessment appears to have a strong negative linear relation with VO2max in PCOS. No relation was found in controls.

Conclusions: Our data demonstrate a reduced cardiopulmonary functional capacity in young PCOS patients.




This article has been cited by other articles:


Home page
DiabetesHome page
V. Skov, D. Glintborg, S. Knudsen, T. Jensen, T. A. Kruse, Q. Tan, K. Brusgaard, H. Beck-Nielsen, and K. Hojlund
Reduced Expression of Nuclear-Encoded Genes Involved in Mitochondrial Oxidative Metabolism in Skeletal Muscle of Insulin-Resistant Women With Polycystic Ovary Syndrome
Diabetes, September 1, 2007; 56(9): 2349 - 2355.
[Abstract] [Full Text] [PDF]


Home page
Eur J EndocrinolHome page
F. Orio, F. Manguso, S. Di Biase, A. Falbo, F. Giallauria, D. Labella, A. Tolino, G. Lombardi, A. Colao, and S. Palomba
Metformin administration improves leukocyte count in women with polycystic ovary syndrome: a 6-month prospective study
Eur. J. Endocrinol., July 1, 2007; 157(1): 69 - 73.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
C. Vigorito, F. Giallauria, S. Palomba, T. Cascella, F. Manguso, R. Lucci, A. De Lorenzo, D. Tafuri, G. Lombardi, A. Colao, et al.
Beneficial Effects of a Three-Month Structured Exercise Training Program on Cardiopulmonary Functional Capacity in Young Women with Polycystic Ovary Syndrome
J. Clin. Endocrinol. Metab., April 1, 2007; 92(4): 1379 - 1384.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2006 by The Endocrine Society